Sandhoff
Showing 1 - 25 of 31
GM2 Gangliosidosis, Supportive Care Trial in Kashan, Mashhad, Tehran (Miglustat)
Recruiting
- GM2 Gangliosidosis
- Supportive Care
-
Kashan, Isfahan, Iran, Islamic Republic of
- +2 more
Oct 23, 2022
A Natural History Study of the Gangliosidoses
Recruiting
- Tay-Sachs Disease
- +4 more
-
Minneapolis, MinnesotaUniversity of Minnesota - Pediatric Genetics and Metabolism
Feb 28, 2022
Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II Trial in Durham (DUOC-01)
Recruiting
- Adrenoleukodystrophy
- +11 more
- DUOC-01
-
Durham, North CarolinaDuke University Medical Center
Oct 24, 2022
GM1 and GM2 Gangliosidosis PROspective Neurological Disease
Recruiting
- GM1 Gangliosidosis
- +2 more
-
Oakland, California
- +12 more
Nov 16, 2022
Tay-Sachs Disease, Sandhoff Disease Trial in Boston, Worcester (AXO-AAV-GM2 Starting Dose, AXO-AAV-GM2 Low Dose, AXO-AAV-GM2
Recruiting
- Tay-Sachs Disease
- Sandhoff Disease
- AXO-AAV-GM2 Starting Dose
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2021
The Natural History of Metachromatic Leukodystrophy
Recruiting
- MLD
- +26 more
- Palliative Care
- Hematopoetic Stem Cell Transplantation
-
Pittsburgh, PennsylvaniaThe Program for the Study of Neurodevelopment in Rare Disorders,
Nov 2, 2021
GM1 Gangliosidoses, GM2 Gangliosidoses, Tay-Sachs Disease Trial in Minneapolis (miglustat, Ketogenic Diet)
Terminated
- GM1 Gangliosidoses
- +3 more
- miglustat
- Ketogenic Diet
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 18, 2021
Gangliosidoses, GM1 Gangliosidosis, Morquio B Disease Trial in Hochheim
Recruiting
- Gangliosidoses
- +8 more
-
Hochheim, HE, GermanySphinCS Lyso gemeinnützige UG (haftungsbeschränkt)
Nov 5, 2020
Tay-Sachs Disease Sandhoff Disease Trial in Worldwide (venglustat GZ402671, )
Active, not recruiting
- Tay-Sachs Disease Sandhoff Disease
- venglustat GZ402671
- placebo
-
Los Angeles, California
- +23 more
Jan 31, 2022
Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders
Recruiting
- Neurological Regression
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Infantile GM2 Gangliosidosis (Disorder) Trial in Kingston (TSHA-101)
Active, not recruiting
- Infantile GM2 Gangliosidosis (Disorder)
- TSHA-101
-
Kingston, Ontario, CanadaQueen's University/Kingston Health Sciences Centre
Sep 12, 2022
Ewing Sarcoma Trial in Warsaw (Naxitamab)
Not yet recruiting
- Ewing Sarcoma
-
Warsaw, Mazowian, PolandMother and Child Institute
Jul 28, 2023
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
Active, not recruiting
- Hepato-splenomegaly
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (drug, procedure,
Completed
- Adrenoleukodystrophy
- +8 more
- Clofarabine
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jul 10, 2019
Diabetes, Type 2 Trial in Hong Kong (Simvastatin 10mg, Ezetimibe 10mg)
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Simvastatin 10mg
- Ezetimibe 10mg
-
Hong Kong, Hong KongDiabetes Centre, 2/F, Block L, Department of Medicine, Queen Mar
Nov 21, 2022
Peripheral Artery Disease Trial in Aurora (Intervention A - Vascular Care + site 6MWT administration, Intervention B - Standard
Recruiting
- Peripheral Artery Disease
- Intervention A - Vascular Care + site 6MWT administration
- +3 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 22, 2021
GM2 Gangliosidosis Trial in Boston
Recruiting
- GM2 Gangliosidosis
-
Boston, MassachusettsMassachusetts General Hospital
Sep 8, 2020
Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (Stem Cell Transplant,
Completed
- Adrenoleukodystrophy
- +10 more
- Stem Cell Transplant
- Busulfan, Cyclophosphamide, Antithymocyte Globulin
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Stroke, Hemiplegia Trial in San Diego (Theraband with exercise video, usual care with advice to exercise)
Completed
- Stroke
- Hemiplegia
- Theraband with exercise video
- usual care with advice to exercise
-
San Diego, CaliforniaKaiser Permanente
Aug 21, 2018
Lysosomal Storage Disease, Peroxisomal Disorder Trial in Minneapolis (drug, radiation, biological)
Completed
- Lysosomal Storage Disease
- Peroxisomal Disorder
- Campath-1H
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Lysosomal Storage Diseases, Inborn Errors of Metabolism Trial in Durham (ALD-601)
Withdrawn
- Lysosomal Storage Diseases
- Inborn Errors of Metabolism
- ALD-601
-
Durham, North Carolina
- +1 more
Jun 27, 2017
Gangliosidoses GM2 Trial in Toronto (miglustat)
Completed
- Gangliosidoses GM2
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
May 18, 2016
Phosphoglycerate Kinase (PGK) Deficiency Trial in Nashville (Unrelated Donor BMT)
Completed
- Phosphoglycerate Kinase (PGK) Deficiency
- Unrelated Donor BMT
-
Nashville, TennesseeVanderbilt Children's Hospital
Nov 22, 2016
Peripheral Arterial Disease Trial in Porto Alegre (Device: treadmill, Device: treadmill Train_Comb_aerobic)
Unknown status
- Peripheral Arterial Disease
- Device: treadmill
- Device: treadmill Train_Comb_aerobic
-
Porto Alegre, Rio Grande do Sul, BrazilHospital De Clínicas de Porto Alegre
Mar 31, 2016
Gene Therapy for Tay-Sachs Disease
Completed
- Tay Sachs Disease
- +2 more
-
Tampa, Florida
- +1 more
Dec 3, 2014